Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Revenues: | ||||
| Revenues | $ 8,430,000 | $ 7,071,000 | $ 15,514,000 | $ 13,183,000 |
| Costs of revenue: | ||||
| Maintenance and supplies | 743,000 | 656,000 | 1,556,000 | 1,266,000 |
| Depreciation and amortization | 1,341,000 | 1,497,000 | 2,630,000 | 2,942,000 |
| Other direct operating costs | 4,683,000 | 3,088,000 | 8,129,000 | 5,952,000 |
| Other direct operating costs, related party | 230,000 | 200,000 | 478,000 | 451,000 |
| Cost of Revenue | 6,997,000 | 5,441,000 | 12,793,000 | 10,611,000 |
| Gross margin | 1,433,000 | 1,630,000 | 2,721,000 | 2,572,000 |
| Selling and administrative expense | 2,042,000 | 1,746,000 | 3,952,000 | 3,554,000 |
| Interest expense | 301,000 | 428,000 | 603,000 | 861,000 |
| Operating loss | (910,000) | (544,000) | (1,834,000) | (1,843,000) |
| Interest and other income, net | 47,000 | 45,000 | 101,000 | 109,000 |
| Loss before income taxes | (863,000) | (499,000) | (1,733,000) | (1,734,000) |
| Income tax expense (benefit) | 135,000 | (21,000) | 227,000 | (344,000) |
| Net loss | (998,000) | (478,000) | (1,960,000) | (1,390,000) |
| Less: net loss attributable to non-controlling interests | 484,000 | 198,000 | 834,000 | 485,000 |
| Net loss attributable to American Shared Hospital Services | $ (514,000) | $ (280,000) | $ (1,126,000) | $ (905,000) |
| Net loss per share: | ||||
| Basic loss per share (in dollars per share) | $ (0.07) | $ (0.04) | $ (0.17) | $ (0.14) |
| Diluted loss per share (in dollars per share) | $ (0.07) | $ (0.04) | $ (0.17) | $ (0.14) |
| Weighted average common shares for basic loss per share (in shares) | 6,872,000 | 6,582,000 | 6,737,000 | 6,577,000 |
| Weighted average common shares for diluted loss per share (in shares) | 6,872,000 | 6,582,000 | 6,737,000 | 6,577,000 |
| Rental Income from Medical Services [Member] | ||||
| Revenues: | ||||
| Revenues | $ 3,545,000 | $ 3,571,000 | $ 6,565,000 | $ 6,562,000 |
| Patient Income [Member] | ||||
| Revenues: | ||||
| Revenues | $ 4,885,000 | $ 3,500,000 | $ 8,949,000 | $ 6,621,000 |
| X | ||||||||||
- Definition The amount of interest income (loss) and other income (loss) recognized during the period. No definition available.
|
| X | ||||||||||
- Definition Other costs from related parties incurred during the reporting period related to other revenue generating activities. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for allocation of cost of tangible and intangible assets over their useful lives, and reduction in quantity of natural resource due to consumption directly used in production of good and rendering of service. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Costs of maintenance supplies used that are directly related to goods produced and sold, or services rendered, during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Other costs incurred during the reporting period related to other revenue generating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|